scholarly journals Beta-Ketothiolase Deficiency as A Treatable Neurometabolic Disorder: A Case Report Due to A Novel Compound Heterozygote Mutations in ACAT1 Gene

Author(s):  
Ali Reza Tavasoli
2018 ◽  
Vol 2 (4) ◽  
Author(s):  
Eliza Jeanette McConnell ◽  
James Every ◽  
Michel Tchan ◽  
Rebecca Kozor

Medicina ◽  
2020 ◽  
Vol 56 (8) ◽  
pp. 387
Author(s):  
Francesco Calì ◽  
Maurizio Elia ◽  
Mirella Vinci ◽  
Luigi Vetri ◽  
Edvige Correnti ◽  
...  

The DHRS9 gene is involved in several pathways including the synthesis of allopregnanolone from progesterone. Allopregnanolone is a positive modulator of gamma aminobutyric acid (GABA) action and plays a role in the control of neuronal excitability and seizures. Whole-exome sequencing performed on a girl with an early onset epilepsy revealed that she was a compound heterozygote for two novel missense mutations of the DHRS9 gene likely to disrupt protein function. No previous studies have reported the implication of this gene in epilepsy. We discuss a new potential pathogenic mechanism underlying epilepsy in a child, due to a defective progesterone pathway.


2021 ◽  
Vol 10 (4) ◽  
pp. 1026-1033
Author(s):  
Jia Li ◽  
Qing Lu ◽  
Jianyu Yu ◽  
Min Ji ◽  
Liangjing Lu

2021 ◽  
Author(s):  
jiaying cao ◽  
lu xu ◽  
jiahua pan

Abstract Background: Fructose-1,6-bisphosphatase (FBPase) deficiency is a rare disorder of glucose metabolism, mainly revealed by hypoglycemia and lactic acidosis. The disease is caused by a mutation of FBP1 gene, which is clustered in a 31-kb region on chromosome 9q22. Case presentation: We described a two-and-half-year-old boy diagnosed as FBPase deficiency. The result of gene analysis showed that the patient had a compound heterozygote for the G164S and P308R, respectively inherited from his father and mother. To some degree, mutations are associated with activity of enzyme, which is corresponding to the level of glucose and extent of brain damage. Patients are advised to reduce intake of fructose and sucrose and avoid long-term fasting in order to reduce the risk of metabolic decompensation. Conclusions: This report would like to provide profound insights of FBPase deficiency.


2019 ◽  
Vol 60 (3) ◽  
pp. 246-249
Author(s):  
Mirjana Turkalj ◽  
Vid Matišić ◽  
Arijana Šimić ◽  
Alen Juginović ◽  
Damir Erceg ◽  
...  

Author(s):  
Shuo Guo ◽  
Huiyu Zhong ◽  
Bi Zhao ◽  
Dan Yang ◽  
Zirui Meng ◽  
...  

2021 ◽  
Vol 8 ◽  
pp. 2329048X2110310
Author(s):  
Daniel I. Weiman ◽  
Meredith K. Gillespie ◽  
Taila Hartley ◽  
Matthew Osmond ◽  
Yoko Ito ◽  
...  

Allgrove or “Triple A” syndrome is characterized by alacrima, achalasia, and adrenocorticotropic hormone-resistant adrenal insufficiency, as well as central and peripheral nervous system involvement. Patients demonstrate heterogeneity with regard to their age of symptom onset, disease severity, and nature of clinical symptoms. Neurophysiological testing has also shown variability ranging from: motor neuron disease with prominent bulbar involvement, motor-predominant neuropathy, or sensorimotor polyneuropathy with axonal or mixed axonal and demyelinating features. We report an 11-year-old boy who presented with neurological symptoms of progressive spasticity and peripheral neuropathy. His neurophysiological testing confirmed a sensorimotor polyneuropathy with axonal and demyelinating features. Exome sequencing identified compound heterozygote variants in the AAAS gene. We summarize the neurophysiological findings in him and 29 other patients with Allgrove syndrome where nerve conduction study findings were available thereby providing a review of the heterogeneity in neurophysiological findings that have been reported in this rare disorder.


Sign in / Sign up

Export Citation Format

Share Document